The US Food and Drug Administration (FDA) has approved lubiprostone (Amitiza, Sucampo Pharmaceuticals Inc/Takeda Pharmaceuticals USA Inc), the first oral treatment for opioid-induced constipation in adults with chronic noncancer pain. Leggi il resto dell’articolo…

Continue reading about FDA Approves Amitiza for Opioid-Induced Constipation